BRAF and thyroid gland papillary carcinoma: Endocannabinoids were effective against cancer cells with activated BRAF/ERK and/or TrkA signaling, suggesting their potential utility for the treatment of BRAF-positive papillary thyroid carcinoma (PTC) and TrkA-positive medullary thyroid cancer [107].